Logo image of ADNT

ADIENT PLC (ADNT) Stock Fundamental Analysis

NYSE:ADNT - New York Stock Exchange, Inc. - IE00BD845X29 - Common Stock - Currency: USD

16.94  -0.29 (-1.68%)

After market: 16.94 0 (0%)

Fundamental Rating

4

ADNT gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 83 industry peers in the Automobile Components industry. ADNT may be in some trouble as it scores bad on both profitability and health. ADNT is valued quite cheap, while showing a decent growth score. This is a good combination!


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year ADNT was profitable.
In the past year ADNT had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: ADNT reported negative net income in multiple years.
Each year in the past 5 years ADNT had a positive operating cash flow.
ADNT Yearly Net Income VS EBIT VS OCF VS FCFADNT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B -1B -1.5B

1.2 Ratios

ADNT has a Return On Assets of -0.02%. This is in the lower half of the industry: ADNT underperforms 78.31% of its industry peers.
ADNT's Return On Equity of -0.11% is on the low side compared to the rest of the industry. ADNT is outperformed by 77.11% of its industry peers.
ADNT has a worse Return On Invested Capital (5.97%) than 72.29% of its industry peers.
The Average Return On Invested Capital over the past 3 years for ADNT is below the industry average of 9.58%.
The last Return On Invested Capital (5.97%) for ADNT is above the 3 year average (5.11%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA -0.02%
ROE -0.11%
ROIC 5.97%
ROA(3y)0.35%
ROA(5y)1.2%
ROE(3y)1.42%
ROE(5y)1.16%
ROIC(3y)5.11%
ROIC(5y)4.23%
ADNT Yearly ROA, ROE, ROICADNT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 -60

1.3 Margins

ADNT's Profit Margin has declined in the last couple of years.
The Operating Margin of ADNT (2.86%) is worse than 79.52% of its industry peers.
In the last couple of years the Operating Margin of ADNT has grown nicely.
Looking at the Gross Margin, with a value of 6.18%, ADNT is doing worse than 91.57% of the companies in the same industry.
ADNT's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 2.86%
PM (TTM) N/A
GM 6.18%
OM growth 3Y-7.97%
OM growth 5Y33.2%
PM growth 3Y-75.27%
PM growth 5YN/A
GM growth 3Y-5.89%
GM growth 5Y5.44%
ADNT Yearly Profit, Operating, Gross MarginsADNT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5

3

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), ADNT is creating some value.
Compared to 1 year ago, ADNT has less shares outstanding
ADNT has less shares outstanding than it did 5 years ago.
The debt/assets ratio for ADNT has been reduced compared to a year ago.
ADNT Yearly Shares OutstandingADNT Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
ADNT Yearly Total Debt VS Total AssetsADNT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.2 Solvency

An Altman-Z score of 1.88 indicates that ADNT is not a great score, but indicates only limited risk for bankruptcy at the moment.
ADNT has a Altman-Z score of 1.88. This is in the lower half of the industry: ADNT underperforms 73.49% of its industry peers.
ADNT has a debt to FCF ratio of 7.15. This is a slightly negative value and a sign of low solvency as ADNT would need 7.15 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 7.15, ADNT is doing worse than 71.08% of the companies in the same industry.
A Debt/Equity ratio of 1.28 is on the high side and indicates that ADNT has dependencies on debt financing.
ADNT's Debt to Equity ratio of 1.28 is on the low side compared to the rest of the industry. ADNT is outperformed by 87.95% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.28
Debt/FCF 7.15
Altman-Z 1.88
ROIC/WACC1.19
WACC5.01%
ADNT Yearly LT Debt VS Equity VS FCFADNT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B

2.3 Liquidity

ADNT has a Current Ratio of 1.08. This is a normal value and indicates that ADNT is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.08, ADNT is not doing good in the industry: 91.57% of the companies in the same industry are doing better.
A Quick Ratio of 0.86 indicates that ADNT may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.86, ADNT is doing worse than 84.34% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.08
Quick Ratio 0.86
ADNT Yearly Current Assets VS Current LiabilitesADNT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

4

3. Growth

3.1 Past

The earnings per share for ADNT have decreased strongly by -14.62% in the last year.
The Earnings Per Share has been growing slightly by 2.56% on average over the past years.
The Revenue has decreased by -5.42% in the past year.
The Revenue has been decreasing by -2.33% on average over the past years.
EPS 1Y (TTM)-14.62%
EPS 3Y-3.98%
EPS 5Y2.56%
EPS Q2Q%-12.9%
Revenue 1Y (TTM)-5.42%
Revenue growth 3Y2.4%
Revenue growth 5Y-2.33%
Sales Q2Q%-4.51%

3.2 Future

Based on estimates for the next years, ADNT will show a very strong growth in Earnings Per Share. The EPS will grow by 34.76% on average per year.
The Revenue is expected to grow by 1.52% on average over the next years.
EPS Next Y-4.49%
EPS Next 2Y20.77%
EPS Next 3Y29.58%
EPS Next 5Y34.76%
Revenue Next Year-4.72%
Revenue Next 2Y-1.7%
Revenue Next 3Y-0.67%
Revenue Next 5Y1.52%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
ADNT Yearly Revenue VS EstimatesADNT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 5B 10B 15B 20B
ADNT Yearly EPS VS EstimatesADNT Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0 2 4 6 8

7

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 9.36, the valuation of ADNT can be described as reasonable.
Compared to the rest of the industry, the Price/Earnings ratio of ADNT indicates a somewhat cheap valuation: ADNT is cheaper than 73.49% of the companies listed in the same industry.
When comparing the Price/Earnings ratio of ADNT to the average of the S&P500 Index (29.63), we can say ADNT is valued rather cheaply.
The Price/Forward Earnings ratio is 6.28, which indicates a rather cheap valuation of ADNT.
Based on the Price/Forward Earnings ratio, ADNT is valued cheaper than 83.13% of the companies in the same industry.
ADNT is valuated cheaply when we compare the Price/Forward Earnings ratio to 22.68, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 9.36
Fwd PE 6.28
ADNT Price Earnings VS Forward Price EarningsADNT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

77.11% of the companies in the same industry are more expensive than ADNT, based on the Enterprise Value to EBITDA ratio.
ADNT's Price/Free Cash Flow ratio is rather cheap when compared to the industry. ADNT is cheaper than 87.95% of the companies in the same industry.
Industry RankSector Rank
P/FCF 4.23
EV/EBITDA 3.98
ADNT Per share dataADNT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 50 100 150

4.3 Compensation for Growth

A more expensive valuation may be justified as ADNT's earnings are expected to grow with 29.58% in the coming years.
PEG (NY)N/A
PEG (5Y)3.65
EPS Next 2Y20.77%
EPS Next 3Y29.58%

0

5. Dividend

5.1 Amount

No dividends for ADNT!.
Industry RankSector Rank
Dividend Yield N/A

ADIENT PLC

NYSE:ADNT (2/21/2025, 8:04:00 PM)

After market: 16.94 0 (0%)

16.94

-0.29 (-1.68%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupAutomobiles & Components
GICS IndustryAutomobile Components
Earnings (Last)01-28 2025-01-28/bmo
Earnings (Next)05-01 2025-05-01/amc
Inst Owners102.52%
Inst Owner Change-98.27%
Ins Owners0.86%
Ins Owner Change14.61%
Market Cap1.42B
Analysts52.5
Price Target21.8 (28.69%)
Short Float %6.46%
Short Ratio4.37
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)33.62%
Min EPS beat(2)27.59%
Max EPS beat(2)39.64%
EPS beat(4)3
Avg EPS beat(4)10.71%
Min EPS beat(4)-49.75%
Max EPS beat(4)39.64%
EPS beat(8)4
Avg EPS beat(8)9.65%
EPS beat(12)6
Avg EPS beat(12)12.16%
EPS beat(16)8
Avg EPS beat(16)-9.78%
Revenue beat(2)1
Avg Revenue beat(2)0.76%
Min Revenue beat(2)-0.06%
Max Revenue beat(2)1.57%
Revenue beat(4)1
Avg Revenue beat(4)-1.55%
Min Revenue beat(4)-4.77%
Max Revenue beat(4)1.57%
Revenue beat(8)3
Avg Revenue beat(8)-0.98%
Revenue beat(12)4
Avg Revenue beat(12)-0.7%
Revenue beat(16)6
Avg Revenue beat(16)-0.83%
PT rev (1m)-11.35%
PT rev (3m)-17.39%
EPS NQ rev (1m)-21.36%
EPS NQ rev (3m)-67.49%
EPS NY rev (1m)-11.74%
EPS NY rev (3m)-32.83%
Revenue NQ rev (1m)-4.58%
Revenue NQ rev (3m)-11.32%
Revenue NY rev (1m)-1.98%
Revenue NY rev (3m)-4.9%
Valuation
Industry RankSector Rank
PE 9.36
Fwd PE 6.28
P/S 0.1
P/FCF 4.23
P/OCF 2.33
P/B 0.76
P/tB N/A
EV/EBITDA 3.98
EPS(TTM)1.81
EY10.68%
EPS(NY)2.7
Fwd EY15.93%
FCF(TTM)4
FCFY23.63%
OCF(TTM)7.28
OCFY42.97%
SpS173.04
BVpS22.36
TBVpS-6.65
PEG (NY)N/A
PEG (5Y)3.65
Profitability
Industry RankSector Rank
ROA -0.02%
ROE -0.11%
ROCE 7.86%
ROIC 5.97%
ROICexc 7.13%
ROICexgc 15.86%
OM 2.86%
PM (TTM) N/A
GM 6.18%
FCFM 2.31%
ROA(3y)0.35%
ROA(5y)1.2%
ROE(3y)1.42%
ROE(5y)1.16%
ROIC(3y)5.11%
ROIC(5y)4.23%
ROICexc(3y)6.22%
ROICexc(5y)5.21%
ROICexgc(3y)13.54%
ROICexgc(5y)10.98%
ROCE(3y)6.73%
ROCE(5y)5.58%
ROICexcg growth 3Y4.55%
ROICexcg growth 5Y38.95%
ROICexc growth 3Y0.66%
ROICexc growth 5Y34.59%
OM growth 3Y-7.97%
OM growth 5Y33.2%
PM growth 3Y-75.27%
PM growth 5YN/A
GM growth 3Y-5.89%
GM growth 5Y5.44%
F-Score4
Asset Turnover1.7
Health
Industry RankSector Rank
Debt/Equity 1.28
Debt/FCF 7.15
Debt/EBITDA 3.22
Cap/Depr 83.59%
Cap/Sales 1.89%
Interest Coverage 250
Cash Conversion 82.12%
Profit Quality N/A
Current Ratio 1.08
Quick Ratio 0.86
Altman-Z 1.88
F-Score4
WACC5.01%
ROIC/WACC1.19
Cap/Depr(3y)73.03%
Cap/Depr(5y)79.22%
Cap/Sales(3y)1.69%
Cap/Sales(5y)1.91%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-14.62%
EPS 3Y-3.98%
EPS 5Y2.56%
EPS Q2Q%-12.9%
EPS Next Y-4.49%
EPS Next 2Y20.77%
EPS Next 3Y29.58%
EPS Next 5Y34.76%
Revenue 1Y (TTM)-5.42%
Revenue growth 3Y2.4%
Revenue growth 5Y-2.33%
Sales Q2Q%-4.51%
Revenue Next Year-4.72%
Revenue Next 2Y-1.7%
Revenue Next 3Y-0.67%
Revenue Next 5Y1.52%
EBIT growth 1Y-15.65%
EBIT growth 3Y-5.76%
EBIT growth 5Y30.09%
EBIT Next Year64.81%
EBIT Next 3Y24.36%
EBIT Next 5Y24.16%
FCF growth 1Y223.08%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y84.04%
OCF growth 3Y30.56%
OCF growth 5Y12.01%